Daniel Rueda-Fernández

5PUBLICATIONS
33CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 06, 2025
Co-targeting SRC overcomes resistance to BRAF inhibitors in colorectal cancer.

Beatriz Rubio-Cuesta, Carlos Carretero-Puche, Patricia Llamas

|Nov 02, 2022
Biallelic germline mutations in MAD1L1 induce a syndrome of aneuploidy with high tumor susceptibility.

Carolina Villarroya-Beltri, Ana Osorio, Raúl Torres-Ruiz

|Jan 21, 2022
Genomic Landscape of Vinflunine Response in Metastatic Urothelial Cancer.

Alejandra Bernardini, Marta Dueñas, María Cruz Martín-Soberon

|Jun 24, 2021
A systematic CRISPR screen defines mutational mechanisms underpinning signatures caused by replication errors and endogenous DNA damage.

Xueqing Zou, Gene Ching Chiek Koh, Arjun Scott Nanda

|Dec 05, 2019
Association of Polyps with Early-Onset Colorectal Cancer and Throughout Surveillance: Novel Clinical and Molecular Implications.

José Perea García, Julia Arribas, Ángel Cañete

Pageof 1

Frequent Collaborators

2 joint publications

José Perea García

2 joint publications

David Gómez-Sánchez

1 joint publications

Juan Luis García

1 joint publications

Edurne Álvaro